Optimal laser fiber rotational movement during photoselective vaporization of the prostate in a bovine ex-vivo animal model

Journal of Endourology

Volumn 25, Issue 7, 2011, Pages 1209-1215

  Osterberg, E Charles ^a   Kauffman, Eric C ^a   Kang, Hyun Wook ^b   Koullick, Ed ^c   Choi, Benjamin B ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b American Medical Systems   (United States)

^c American Medical Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; BLOOD CLOTTING; COMPUTER; CONFERENCE PAPER; CYTOREDUCTIVE SURGERY; EX VIVO STUDY; EXPERIMENTAL MODEL; LASER SURGERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE PHOTOSELECTIVE VAPORIZATION; PROSTATE SURGERY; SURGICAL TECHNIQUE; VAPORIZATION; VIDEORECORDING;

ANIMALS; CATTLE; LASER THERAPY; LASERS; MALE; MODELS, ANIMAL; MOVEMENT; PROSTATE; ROTATION; VIDEO RECORDING;

EID: 79960243951     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2010.0600     Document Type: Conference Paper

References (33)

1. Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474-479 (Pubitemid 14026148)
2. Choi BB, Tabatabaei S, Bachmann A, et al. Greenlight HPS 120-W laser for benign prostatic hyperplasia: Comparative complications and technical recommendations. Eur Urol 2008;suppl 7, 384-392.
3. Borboroglu PG, Kane CJ, Ward JF, et al. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999;162:1307-1310. (Pubitemid 29428568)
4. Hahn RG. Smoking increases the risk of large scale fluid absorption during transurethral prostatic resection. J Urol 2001;166:162-165. (Pubitemid 32565369)
5. Muzzonigro G, Milanese G, Minardi D, et al. Safety and efficacy of transurethral resection of prostate glands up to 150 ml: A prospective comparative study with 1 year of followup. J Urol 2004;172:611-615. (Pubitemid 38900218)
6. Muntener M, Aellig S, Kuettel R, et al. Sexual function after transurethral resection of the prostate (TURP): Results of an independent prospective multicentre assessment of outcome. Eur Urol 2007;52:510-515.
7. Al-Ansari A, Younes N, Sampige VP, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: A randomized clinical trial with midterm follow-up. EEur Urol 2010;58:349-355.
8. Hai MA, Malek RS. Photoselective vaporization of the prostate: Initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003;17:93-96. (Pubitemid 36348884)
9. Malek RS, Barrett DM, Kuntzman RS.High-power potassiumtitanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 1998;51:254-256. (Pubitemid 28093177)
10. Malek RS, Kang HW, Coad JE, Koullick E. Greenlight photoselective 120-watt 532-nm lithium triborate laser vaporization prostatectomy in living canines. J Endourol 2009;23:837-845.
11. Bachmann A, Schü rch L, Ruszat R, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): A prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48:965-972. (Pubitemid 41641646)
12. Bouchier-Hayes DM, Anderson P, Van Appledorn S, et al. KTP laser versus transurethral resection: Early results of a randomized trial. J Endourol 2006;20:580-585. (Pubitemid 44689646)
13. Horasanli K, Silay MS, Altay B, et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: A short-term prospective randomized trial. Urology 2008;71:247-251. (Pubitemid 351282348)
14. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl- phosphate laser vaporization of the benign obstructive prostate: Observations on long-term outcomes. J Urol 2005;174:1344-1348. (Pubitemid 41318725)
15. Ruszat R, Wyler SF, Seitz M, et al. Comparison of potassium-titanyl- phosphate laser vaporization of the prostate and transurethral resection of the prostate: Update of a prospective non-randomized two-centre study. BJU Int 2008;102:1432-1439.
16. Pfitzenmaier J, Gilfrich C, Pritsch M, et al. Vaporization of prostates of > or = 80mL using a potassium-titanyl-phosphate laser: Midterm-results and comparison with prostates of (Pubitemid 352019188)
17. Rajbabu K, Chandrasekara SK, Barber NJ, et al. Photoselective vaporization of the prostate with the potassiumtitanyl-phosphate laser in men with prostates of > 100 mL. BJU Int 2007;100:593-598. (Pubitemid 47205451)
18. Reich O, Bachmann A, Siebels M, et al. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005;173:158-160. (Pubitemid 39627700)
19. Ruszat R, Wyler S, Forster T, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007;51:1031-1041. (Pubitemid 46281412)
20. Sandhu JS, Ng C, Vanderbrink BA, et al. High-power potassium-titanyl- phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004;64:1155.
21. Sandhu JS, Ng CK, Gonzalez RR, et al. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005;19:1196-1198. (Pubitemid 43082914)
22. Tasci AI, Tugcu V, Sahin S, Zorluoglu F. Rapid communication: Photoselective vaporization of the prostate versus transurethral resection of the prostate for the large prostate: A prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008;22:347-353. (Pubitemid 351301341)
23. Yuan J, Wang H, Wu G, et al. High-power (80 W) potassium titanyl phosphate laser prostatectomy in 128 high-risk patients. Postgrad Med J 2008;84:46-49. (Pubitemid 351236581)
24. Hai MA. Photoselective vaporization of prostate: Five-year outcomes of entire clinic patient population. Urology 2009;73:807-810.
25. Goh AC, Gonzalez RR. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: A cost analysis. J Urol 2010;183:1469-1473.
26. Lee R, Saini R, Zoltan E, et al. Photoselective vaporization of the prostate using a laser high performance system in the canine model. J Urol 2008;180:1551.
27. Spaliviero M, Araki M, Culkin DJ, Wong C. Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J Endourol 2009;23:495-502.
28. Spaliviero M, Araki M, Wong C. Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol 2008;22:2341-2347.
29. Gómez Sancha F, Bachmann A, Choi BB, et al. Photoselective vaporization of the prostate (GreenLight PV): Lessons learnt after 3500 procedures. Prostate Cancer Prostatic Dis 2007; 10:316-322. (Pubitemid 350238078)
30. Kauffman EC, Kang HW, Choi BB. The effect of laser-fiber sweeping speed on the efficiency of photoselective vaporization of the prostate in an ex vivo bovine model. J Endourol 2009;23:1429-1435.
31. Kang HW, Jebens D, Malek RS, et al. Laser vaporization of bovine prostate: A quantitative comparison of potassiumtitanyl-phosphate and lithium triborate lasers. J Urol 2008;180:2675-2680.
32. Kang HW, Peng YS, Stinson D. Quantitative evaluation of high power effect on 532nm laser vaporization of bovine prostate in vitro. J Urol 2010;184:1211-1215.
33. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. Highpower (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 1997;49:703-708. (Pubitemid 27194585)